B-Myb: a key regulator of the cell cycle.

[1]  S. Aaronson,et al.  Differential expression of the amv gene in human hematopoietic cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[2]  M. Groudine,et al.  Levels of c-myc oncogene mRNA are invariant throughout the cell cycle , 1985, Nature.

[3]  M. Groudine,et al.  Expression of the c-myb proto-oncogene during cellular proliferation , 1986, Nature.

[4]  W. Kuehl,et al.  Differential expression of c-myb mRNA in murine B lymphomas by a block to transcription elongation. , 1987, Science.

[5]  Watson Rj.  A transcriptional arrest mechanism involved in controlling constitutive levels of mouse c-myb mRNA. , 1988 .

[6]  N. Nomura,et al.  Isolation of human cDNA clones of myb-related genes, A-myb and B-myb. , 1988, Nucleic acids research.

[7]  T. Nagase,et al.  Delineation of three functional domains of the transcriptional activator encoded by the c-myb protooncogene. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[8]  S. Ishii,et al.  Trans-activation by the c-myb proto-oncogene. , 1989, Nucleic acids research.

[9]  H. Sato,et al.  Expression of human papillomavirus type 16 E7 gene induces DNA synthesis of rat 3Y1 cells. , 1989, Virology.

[10]  J. Bishop,et al.  Transcriptional activation by the v-myb oncogene and its cellular progenitor, c-myb , 1989, Cell.

[11]  J. Azizkhan,et al.  Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo , 1989, Molecular and cellular biology.

[12]  A. Pardee.  G1 events and regulation of cell proliferation. , 1989, Science.

[13]  R. Eisenman,et al.  New light on Myc and Myb. Part II. Myb. , 1990, Genes & development.

[14]  Harold L. Moses,et al.  TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights , 1990, Cell.

[15]  N. Nomura,et al.  DNA binding activity and transcriptional activator function of the human B-myb protein compared with c-MYB. , 1990, The Journal of biological chemistry.

[16]  K. Moelling,et al.  Transcriptional activation by human c-myb and v-myb genes. , 1990, Oncogene.

[17]  E. Krebs,et al.  Myb DNA binding inhibited by phosphorylation at a site deleted during oncogenic activation , 1990, Nature.

[18]  R. Watson,et al.  Characterization of the sequence‐specific interaction of mouse c‐myb protein with DNA. , 1990, The EMBO journal.

[19]  E. Appella,et al.  Wild type human p53 is antiproliferative in SV40-transformed hamster cells. , 1990, Oncogene.

[20]  Weston Km.  The myb genes. , 1990 .

[21]  K. Klempnauer,et al.  Characterization of the v-myb DNA binding domain. , 1990, Nucleic acids research.

[22]  B. Calabretta,et al.  Growth regulated expression of B‐MYB in fibroblasts and hematopoietic cells , 1991, Journal of cellular physiology.

[23]  R. Watson,et al.  Nucleotide preferences in sequence-specific recognition of DNA by c-myb protein. , 1991, Nucleic acids research.

[24]  S. Ishii,et al.  Transformation by carboxyl-deleted Myb reflects increased transactivating capacity and disruption of a negative regulatory domain. , 1991, Oncogene.

[25]  M. Arsura,et al.  Expression of c-myb and B-myb, but not A-myb, correlates with proliferation in human hematopoietic cells , 1991 .

[26]  H. Nasheuer,et al.  Human DNA polymerase alpha gene: sequences controlling expression in cycling and serum-stimulated cells , 1991, Molecular and cellular biology.

[27]  Anne Fernandez,et al.  Cyclin a is required for the onset of DNA replication in mammalian fibroblasts , 1991, Cell.

[28]  Richard A. Ashmun,et al.  Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle , 1991, Cell.

[29]  G. Mizuguchi,et al.  Transcriptional activation of the c-myc gene by the c-myb and B-myb gene products. , 1992, Oncogene.

[30]  M. Introna,et al.  Independent regulation of c-myc, B-myb, and c-myb gene expression by inducers and inhibitors of proliferation in human B lymphocytes. , 1992, Journal of immunology.

[31]  J. Nevins,et al.  The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. , 1992, Genes & development.

[32]  A. Mantovani,et al.  B-myb antisense oligonucleotides inhibit proliferation of human hematopoietic cell lines. , 1992, Blood.

[33]  K. Klempnauer,et al.  Functional antagonism between members of the myb family: B‐myb inhibits v‐myb‐induced gene activation. , 1992, EMBO Journal.

[34]  E. Lam,et al.  Characterization and cell cycle-regulated expression of mouse B-myb. , 1992, Oncogene.

[35]  S. Dalton,et al.  Cell cycle regulation of the human cdc2 gene. , 1992, The EMBO journal.

[36]  R. Eisenman,et al.  Mitosis-specific phosphorylation of the nuclear oncoproteins Myc and Myb , 1992, The Journal of cell biology.

[37]  Constitutive versus cell cycle regulation of c-myb mRNA expression correlates with developmental stages in murine B lymphoid tumors. , 1992, Journal of immunology.

[38]  S. Reed,et al.  Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. , 1992, Genes & development.

[39]  A. Sarai,et al.  Transactivation and transformation by Myb are negatively regulated by a leucine-zipper structure. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[40]  S. Weintraub,et al.  Retinoblastoma protein switches the E2F site from positive to negative element , 1992, Nature.

[41]  R. Pepperkok,et al.  Cyclin A is required at two points in the human cell cycle. , 1992, The EMBO journal.

[42]  T. Bouwmeester,et al.  Molecular cloning, expression and in vitro functional characterization of Myb-related proteins in Xenopus , 1992, Mechanisms of Development.

[43]  J. Lipsick,et al.  Carboxy-terminal elements of c-Myb negatively regulate transcriptional activation in cis and in trans. , 1992, Genes & development.

[44]  E. Appella,et al.  Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[45]  B. Calabretta,et al.  Regulation of BALB/c 3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[46]  K. Robbins,et al.  Diverse biologic properties imparted by the c-fgr proto-oncogene. , 1992, The Journal of biological chemistry.

[47]  S. van den Heuvel,et al.  Distinct roles for cyclin-dependent kinases in cell cycle control. , 1993, Science.

[48]  T. Sturgill,et al.  c-Myb and v-Myb are differentially phosphorylated by p42mapk in vitro. , 1993, Oncogene.

[49]  K. Klempnauer,et al.  TATA-box dependent trans-activation of the human HSP70 promoter by Myb proteins. , 1993, Oncogene.

[50]  S. Shurtleff,et al.  Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. , 1993, Genes & development.

[51]  J. Nevins,et al.  Expression of transcription factor E2F1 induces quiescent cells to enter S phase , 1993, Nature.

[52]  J. Lipsick,et al.  Oncogenic truncation of the first repeat of c-Myb decreases DNA binding in vitro and in vivo , 1993, Molecular and cellular biology.

[53]  M. Pagano,et al.  Cyclin D1 is a nuclear protein required for cell cycle progression in G1. , 1993, Genes & development.

[54]  E. Lam,et al.  An E2F‐binding site mediates cell‐cycle regulated repression of mouse B‐myb transcription. , 1993, The EMBO journal.

[55]  S. Ishii,et al.  Functional domains of the human B-myb gene product. , 1993, The Journal of biological chemistry.

[56]  E. Lam,et al.  Transcription regulation by murine B-myb is distinct from that by c-myb. , 1993, Nucleic acids research.

[57]  J. Whitlock,et al.  Cell cycle‐dependent gene expression in V point‐arrested BALB/c‐3T3 cells , 1993, Journal of cellular physiology.

[58]  R. Weinberg,et al.  Cell cycle-specific association of E2F with the p130 E1A-binding protein. , 1993, Genes & development.

[59]  A. Sarai,et al.  Negative autoregulation of c-Myb activity by homodimer formation through the leucine zipper. , 1993, The Journal of biological chemistry.

[60]  A. Pichler,et al.  A binding site for transcription factor E2F is a target for trans activation of murine thymidine kinase by polyomavirus large T antigen and plays an important role in growth regulation of the gene , 1993, Journal of virology.

[61]  H. Moses,et al.  Inhibition of cell growth by TGF beta 1 is associated with inhibition of B-myb and cyclin A in both BALB/MK and Mv1Lu cells. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[62]  N. Copeland,et al.  Mouse A‐myb encodes a trans‐activator and is expressed in mitotically active cells of the developing central nervous system, adult testis and B lymphocytes. , 1994, The EMBO journal.

[63]  E. Lam,et al.  DP and E2F proteins: coordinating transcription with cell cycle progression. , 1994, Current opinion in cell biology.

[64]  H. Handa,et al.  Multiple nuclear localization signals of the B‐myb gene product , 1994, FEBS letters.

[65]  A. Toscani,et al.  Murine A-myb: evidence for differential splicing and tissue-specific expression. , 1994, Oncogene.

[66]  R. Watson,et al.  The role of Myb proteins in normal and neoplastic cell proliferation. , 1994, Critical reviews in oncogenesis.

[67]  J. Nevins,et al.  Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. , 1994, Genes & development.

[68]  P. Farnham,et al.  Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter. , 1994, Genes & development.

[69]  Liang Zhu,et al.  Interaction of c‐Myc with the pRb‐related protein p107 results in inhibition of c‐Myc‐mediated transactivation. , 1994, The EMBO journal.

[70]  T. Crook,et al.  HPV16 E7 oncoprotein deregulates B‐myb expression: correlation with targeting of p107/E2F complexes. , 1994, The EMBO journal.

[71]  N. L. Thangue,et al.  DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell-cycle control. , 1994 .

[72]  T. Bouwmeester,et al.  Functional aspects of B-Myb in early Xenopus development. , 1994, Oncogene.

[73]  M. Fiscella,et al.  Constitutive expression of B-myb can bypass p53-induced Waf1/Cip1-mediated G1 arrest. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[74]  S. Ross,et al.  The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[75]  K. Klempnauer,et al.  Differential splicing of the mouse B-myb gene. , 1995, Oncogene.

[76]  L. Wolff,et al.  Acceleration of apoptosis in transforming growth factor beta 1-treated M1 cells ectopically expressing B-myb. , 1995, Cancer research.

[77]  E. Harlow,et al.  The pRB‐related protein p107 contains two growth suppression domains: independent interactions with E2F and cyclin/cdk complexes. , 1995, The EMBO journal.

[78]  D. Johnson,et al.  Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity. , 1995, Oncogene.

[79]  P. Raychaudhuri,et al.  Association of p107 with Sp1: genetically separable regions of p107 are involved in regulation of E2F- and Sp1-dependent transcription , 1995, Molecular and cellular biology.

[80]  D. Withers,et al.  Myb binding sites mediate negative regulation of c-myb expression in T-cell lines. , 1995, Blood.

[81]  D. Livingston,et al.  Multiple members of the E2F transcription factor family are the products of oncogenes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[82]  R. Müller,et al.  Transcriptional regulation during the mammalian cell cycle. , 1995, Trends in genetics : TIG.

[83]  M. Oelgeschläger,et al.  Casein kinase II phosphorylation site mutations in c-Myb affect DNA binding and transcriptional cooperativity with NF-M , 1995, Molecular and cellular biology.

[84]  A. Schulze,et al.  Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[85]  B. Calabretta,et al.  Requirement of B- myb Function for Survival and Differentiative Potential of Human Neuroblastoma Cells (*) , 1995, The Journal of Biological Chemistry.

[86]  Lingyun Zhu,et al.  Differential roles of two tandem E2F sites in repression of the human p107 promoter by retinoblastoma and p107 proteins , 1995, Molecular and cellular biology.

[87]  W. Sellers,et al.  Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter , 1994, Molecular and cellular biology.

[88]  L. Neckers,et al.  Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers. , 1995, Molecular pharmacology.

[89]  A. Sarai,et al.  Comparison of the free and DNA-complexed forms of the DMA-binding domain from c-Myb , 1995, Nature Structural Biology.

[90]  S. Reed,et al.  Different roles for cyclins D1 and E in regulation of the G1-to-S transition , 1995, Molecular and cellular biology.

[91]  H. Handa,et al.  Cell type-specific trans-activation by the B-myb gene product: requirement of the putative cofactor binding to the C-terminal conserved domain. , 1995, Oncogene.

[92]  J. Nevins,et al.  Regulation of the cyclin E gene by transcription factor E2F1. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[93]  F. C. Lucibello,et al.  Cell cycle regulation of the cyclin A, cdc25C and cdc2 genes is based on a common mechanism of transcriptional repression. , 1995, The EMBO journal.

[94]  J. Nevins,et al.  Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes , 1995, Molecular and cellular biology.

[95]  E. Lam,et al.  Cell-cycle regulation of human B-myb transcription. , 1995, Gene.

[96]  J. Shabanowitz,et al.  Modulation of c-Myb-induced transcription activation by a phosphorylation site near the negative regulatory domain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[97]  P. McIntosh,et al.  Structure of the B-Myb DNA-binding domain in solution and evidence for multiple conformations in the region of repeat-2 involved in DNA binding: implications for sequence-specific DNA binding by Myb proteins. , 1996, European journal of biochemistry.

[98]  K. Klempnauer,et al.  Expression of B-Myb during mouse embryogenesis. , 1996, Oncogene.

[99]  V. Richon,et al.  Changes in E2F DNA-binding activity during induced erythroid differentiation. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[100]  G. Sonenshein,et al.  B-Myb Expression in Vascular Smooth Muscle Cells Occurs in a Cell Cycle-dependent Fashion and Down-regulates Promoter Activity of Type I Collagen Genes (*) , 1996, The Journal of Biological Chemistry.

[101]  A. Sarai,et al.  Binding site analysis of c-Myb: screening of potential binding sites by using the mutation matrix derived from systematic binding affinity measurements. , 1996, Nucleic acids research.

[102]  F. C. Lucibello,et al.  Cell cycle-regulated repression of B-myb transcription: cooperation of an E2F site with a contiguous corepressor element. , 1996, Nucleic acids research.

[103]  S. Ness,et al.  The EVES motif mediates both intermolecular and intramolecular regulation of c-Myb. , 1996, Genes & development.

[104]  Shiaw-Yih Lin,et al.  Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction , 1996, Molecular and cellular biology.

[105]  C. Peschle,et al.  B-myb Promotes S Phase and Is a Downstream Target of the Negative Regulator p107 in Human Cells (*) , 1996, The Journal of Biological Chemistry.

[106]  B. Calabretta,et al.  B-myb transcriptional regulation and mRNA stability during differentiation of neuroblastoma cells. , 1996, Experimental cell research.

[107]  C. Peschle,et al.  The Retinoblastoma Family Member p107 Binds to B-MYB and Suppresses Its Autoregulatory Activity* , 1996, The Journal of Biological Chemistry.

[108]  G. Peters,et al.  Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. , 1996, Advances in cancer research.

[109]  B. Hoffman,et al.  B-Myb prevents growth arrest associated with terminal differentiation of monocytic cells. , 1996, Oncogene.

[110]  R. Watson,et al.  Cell-cycle regulation of B-Myb protein expression: specific phosphorylation during the S phase of the cell cycle. , 1996, Oncogene.

[111]  A. Sarai,et al.  The cavity in the hydrophobic core of Myb DNA-binding domain is reserved for DNA recognition and trans-activation , 1996, Nature Structural Biology.

[112]  J. Bishop,et al.  myb provides an essential function during Drosophila development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[113]  F. C. Lucibello,et al.  Cell Cycle Regulation of E2F Site Occupation in Vivo , 1996, Science.

[114]  T. Barbui,et al.  Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias , 1996 .

[115]  R. Watson,et al.  E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts. , 1996, Oncogene.

[116]  R. Watson,et al.  B-Myb function can be markedly enhanced by cyclin A-dependent kinase and protein truncation , 1997, Oncogene.

[117]  C. Peschle,et al.  Activation of human B-MYB by cyclins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[118]  R. Müller,et al.  Cell-cycle regulation of gene expression by transcriptional repression. , 1997, Trends in genetics : TIG.